10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2020 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2020 10-K (Filed: Feb 9, 2021) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | |
| Cash flows from operating activities: | |||
| Net income | $ 7,264 | 7,842 | 8,394 |
| Depreciation, amortization and other | 3,601 | 2,206 | 1,946 |
| Stock-based compensation expense | 330 | 308 | 311 |
| Deferred income taxes | (287) | (289) | (363) |
| Other items, net | (195) | (186) | 386 |
| Changes in operating assets and liabilities, net of acquisitions: | |||
| Trade receivables, net | (427) | (504) | (378) |
| Inventories | (215) | (66) | (3) |
| Other assets | 129 | 10 | 35 |
| Accounts payable | 45 | 164 | (143) |
| Accrued income taxes, net | (249) | (585) | (361) |
| Long-term tax liabilities | (482) | (146) | 258 |
| Other liabilities | 983 | 396 | 1,214 |
| Net cash provided by operating activities | 10,497 | 9,150 | 11,296 |
| Cash flows from investing activities: | |||
| Purchases of marketable securities | (8,477) | (9,394) | (18,741) |
| Proceeds from sales of marketable securities | 2,597 | 8,842 | 28,356 |
| Proceeds from maturities of marketable securities | 4,381 | 20,548 | 5,412 |
| Purchases of property, plant and equipment | (608) | (618) | (738) |
| Cash paid for acquisitions, net of cash acquired | 0 | (13,617) | 195 |
| Payments to Acquire Equity Method Investments | (3,219) | (24) | (40) |
| Other | (75) | (28) | (105) |
| Net cash (used in) provided by investing activities | (5,401) | 5,709 | 14,339 |
| Cash flows from financing activities: | |||
| Net proceeds from issuance of debt | 8,914 | 0 | 0 |
| Repayment of debt | (6,450) | (4,514) | (1,121) |
| Repurchases of common stock | (3,486) | (7,702) | (17,794) |
| Dividends paid | (3,755) | (3,509) | (3,507) |
| Other | (90) | (42) | (68) |
| Net cash used in financing activities | (4,867) | (15,767) | (22,490) |
| Increase (decrease) in cash and cash equivalents | 229 | (908) | 3,145 |
| Cash and cash equivalents at beginning of year | 6,037 | 6,945 | |
| Cash and cash equivalents at end of year | 6,266 | 6,037 | 6,945 |
| External Links | |
| AMGEN INC (AMGN) Fiscal Year 2020 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |